November 2024 - Adenosine Receptor Agonists drug patent information, global generic entry, market access

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avet Lifesciences	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	202313-001	Sep 15, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fresenius Kabi Usa	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	077897-002	Nov 27, 2017	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	203883-002	Mar 24, 2014		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	202313-002	Sep 15, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Asi	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	090212-001	Mar 28, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Labs Ltd	ADENOSINE	adenosine	INJECTABLE;INJECTION	078686-001	May 13, 2009	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Asi	ADENOSINE	adenosine	SOLUTION;INTRAVENOUS	090212-002	Mar 28, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration